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Abstract
Background
In the testis, thyroid hormone (T3) regulates the number of gametes produced through its
action on Sertoli cell proliferation. However, the role of T3 in the regulation of steroidogene-
sis is still controversial.
Methods
The TRαAMI knock-in allele allows the generation of transgenic mice expressing a domi-
nant-negative TRα1 (thyroid receptor α1) isoform restricted to specific target cells after Cre-
loxP recombination. Here, we introduced this mutant allele in both Sertoli and Leydig cells
using a novel aromatase-iCre (ARO-iCre) line that expresses Cre recombinase under con-
trol of the human Cyp19(IIa)/aromatase promoter.
Findings
We showed that loxP recombination induced by this ARO-iCre isrestricted to male and fe-
male gonads, and is effective in Sertoli and Leydig cells, but not in germ cells. We compared
this model with the previous introduction of TRαAMI specifically in Sertoli cells in order to in-
vestigate T3 regulation of steroidogenesis. We demonstrated that TRαAMI-ARO males ex-
hibited increased testis weight, increased sperm reserve in adulthood correlated to an
increased proliferative index at P3 in vivo, and a loss of T3-response in vitro. Nevertheless,
TRαAMI-ARO males showed normal fertility. This phenotype is similar to TRαAMI-SC males.
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Importantly, plasma testosterone and luteinizing hormone levels, as well as mRNA levels of
steroidogenesis enzymes StAR, Cyp11a1 and Cyp17a1 were not affected in TRαAMI-ARO.
Conclusions/Significance
We concluded that the presence of a mutant TRαAMI allele in both Leydig and Sertoli cells
does not accentuate the phenotype in comparison with its presence in Sertoli cells only.
This suggests that direct T3 regulation of steroidogenesis through TRα1 is moderate in Ley-
dig cells, and that Sertoli cells are the main target of T3 action in the testis.
Introduction
Thyroid hormones, mainly represented by triiodothyronine (T3), and their nuclear receptors
play important roles in the development, differentiation and function of various organs, in-
cluding the male reproductive system [1,2]. The THRA/NR1A1 and THRB/NR1A2 genes en-
code the T3 nuclear receptors (TRs): TRα1 (thyroid hormone receptor α1) for THRA, and
TRβ1 and TRβ2 for THRB. TRα1 and TRβ1 are expressed ubiquitously. In the testes, T3 is of
particular importance as it regulates the number of gametes produced and the size of the gonad
[3]. It has been proposed that T3 regulates both Sertoli cells (SC), which are specialized sup-
porting cells for germ cells, and Leydig cells (LC) that produce testosterone. The T3 effect relat-
ed to SC is well-known. Indeed, pharmacological approaches [4–6] led to the conclusion that
T3 controls post-natal SC proliferation in vivo. Thereafter, the functional study with homozy-
gous mice bearing a null deletion of the THRA gene (TRαNull/Null mice) showed that TRα1 me-
diates this control [7]. More recently, we demonstrated, using mice with SC-specific TRα1
receptor dominant-negative expression (TRαAMI-SC mice) [8,9], that T3 exerts this regulation
in a direct cell-autonomous manner. Adult LC are the primary source of androgens in mature
mammalian testes, but controversy exists regarding T3-regulation of steroidogenesis. LC arise
from pluripotent mesenchymal precursors (for review see [10,11]), and start to differentiate at
post-natal day 14 (P14) in rats [12] and P10 in mice [13], and gradually mature to adult LC
just before puberty. The effect of T3 on LC has been mostly investigated in rat species, using in
vitro and in vivo pharmacological studies. It is established that T3 is important for mesenchy-
mal stem cell proliferation and differentiation into LC. Indeed, in vivo, exogenous T3 in neo-
nate rats leads to an increase in differentiated LC numbers and influences their proliferation
[14]. The overall impact on steroidogenesis at adulthood is still a matter of debate. In vitro
studies using LC cultures suggest that T3 directly increases steroidogenesis [15]. In rats with
pharmacologically induced hypothyroidism during post-natal development, it has been ob-
served that peripheral testosterone concentrations were unchanged [4,16,17]. However, studies
on neonatal hypothyroid rats showed a decrease in blood testosterone levels at adulthood
[18,19]. Thus, there is a debate about possible T3 regulation of steroidogenesis. Unfortunately,
no genetic evidence supports this matter. In the two previously cited transgenic mouse models
(TRαNull/Null and TRαAMI-SC), we showed that testosterone levels were unchanged. Neverthe-
less, as the modification was restricted to SC in TRαAMI-SC mice and ubiquitously present in
TRαNull/Null mice, these two transgenic lines were not well suited to investigate direct T3 regu-
lation of steroidogenesis by this receptor.
The ubiquitous TRα1 receptor is present in rat LC [20], but no data are yet available in
mice. Following our functional study in TRαAMI-SC mice [8], we aimed to investigate the role
of the TRα1 receptor in the regulation of steroidogenic activity using a novel functional Cre
Phenotype of TRαAMI-AROMice
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transgenic mouse, the aromatase-iCre (ARO-iCre), that we generated in our laboratory and
characterized for this study. After demonstrating the pertinence of this line for Cre-loxP re-
combination in both SC and LC, we produced TRαAMI-ARO mice expressing dominant nega-
tive TRαAMI selectively in SC and LC and compared their phenotypes with the previously
established TRαAMI-SC line at cellular and endocrine levels. The present study confirms our
findings, namely that T3 influences Sertoli cell proliferation through its TRα1 receptor. More-
over, we showed that the expression of dominant-negative TRαAMI in LC does not influence
testosterone production in adulthood.
Materials and Methods
Animals
Mice were maintained under standard conditions of light (12 h light, 12 h darkness) and tem-
perature (21–23°C) with ad libitum access to food and water. All animal studies were con-
ducted in accordance with the guidelines for the care and use of laboratory animals issued by
the French Ministry of Agriculture and with the approval of a local ethical review committee,
under project number 2011-09-10 (Comité d’Ethique en Expérimentation Animale Val de
Loire- n°19). The TRαAMI-ARO line was produced and investigations were performed at the
same time as the TRαAMI-SC, except for steroidogenic enzyme determination. Mice were eu-
thanized by cervical dislocation under anesthesia with ketamine (87 μg/g body weight) and
xylazine (13 μg/g body weight) by intraperitoneal injection. All efforts were made to minimize
animal stress and suffering.
Production of aromatase-iCre (ARO-iCre) line
The aromatase-iCre transgene was generated by placing the cDNA encoding a mammalian
codon-improved Cre recombinase (iCre: [21,22]) followed by an SV40 poly(A) signal under
control of the human Cyp19/aromatase(IIa)-278 promoter cloned by Hinshelwood et al. This
promoter is sufficient to mediate restrictive transgenic expression in the ovary and the testis
[23]. This region contains two response elements, a steroidogenic factor 1-(SF1)-site and a
CRE-like sequence binding CREB protein, critical for cAMP induction of human Cyp19/aro-
matase promoter activity.
To obtain a Cyp19/aromatase-iCre plasmid, the pUChGX plasmid containing the Cyp19/
aromatase(IIa)-278 promoter (a 304 bp fragment stretching between position -278 of 5’-flanking
DNA and +26 of untranslated exon IIa) was HindIII digested, blunted and BamHI digested.
The fragment was cloned into the blunted XbaI and BamHI sites of the pBlue-iCre vector.
Next, a fragment containing the SV40 poly(A) signal was obtained byHindIII digestion, end
blunting and KpnI digestion of the pGEM3Zf-polyA (SV40) plasmid and inserted into the
blunted XhoI and KpnI sites of the Cyp19/aromatase-iCre vector. All DNA constructs were
confirmed by sequencing. The 1,630 bp purified fragment containing the Cyp19/aromatase-
iCre-polyA(SV40) construction was obtained through KpnI and SacI digestion (Fig. 1A). The
transgene was injected into the pronuclei of fertilized eggs frommice with a hybrid DBA/B6 ge-
netic background. Three founder animals (two males and one female) with genomic transgene
integration were detected by PCR as described [24]. Specificity of ARO-iCre loxP excision was
investigated at tissue level by genomic PCR and at cellular level using Cre-loxP reporter mice.
Offspring of all 3 founders targeted Cre specifically to somatic cells of the gonads, without pro-
ducing excision in germ cells. We chose the strain that transmitted the transgene with highest
efficiency to the descendants. This line was called ARO-iCre.
Phenotype of TRαAMI-AROMice
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Generation of TRαAMI-ARO and control mice
The TRαAMI allele generated by Quignodon et al. [25] encodes a TRα1 receptor with a point
mutation changing a leucine to an arginine in the AF-2 domain of the receptor (L400R). This
mutation prevents the recruitment of histone acetyltransferase coactivators, while interaction
with histone deacetylase corepressors is preserved, resulting in dominant-negative activity. The
advantage of this mutation is that repression of transcription is maintained even in the pres-
ence of T3, with heterozygosity being sufficient to achieve the dominant-negative effect. This
mutation is activated by Cre-loxP recombination [25]. According to the procedure we used to
establish TRαAMI-SC from AMH-Cre and TRαAMI/AMI lines [8], we crossed homozygous
TRαAMI/AMI mice (B6/129Sv genetic background) with hemizygous ARO-iCre mice to obtain
Fig 1. Production and characterization of ARO-iCre transgenic mouse line. (a) Schematic diagram of
the DNA construct used for producing ARO-iCre mice. The mammalian codon-improved Cre recombinase
(iCre, 1051 bp; white box) followed by an SV40 poly(A) signal cassette (right grey box) is controlled by 304 bp
of the human Cyp19/aromatase(IIa)-278 promoter (left grey box). Arrows indicate position and direction of
primers. Oligonucleotide sequences are in Table 1. (b) Cre excision is restricted to ovaries (Ov) and testes
(Te) of iCre+/0;IGF1Rflox/WT mice. The excision was only observed in gonads, not in other tissues (He, heart;
Mu, muscle; Lu, lung; Sp, spleen; Br, brain; Li, liver; Pa, pancreas) frommales (M) and females (F). RT-,
negative control (testis cDNA without RT). PCR detected wild-type (W, 256 bp) and floxed (F, 312 bp) alleles
in all tissues, and the excised allele (E, 204 bp) exclusively in gonads. (c)Cre recombinase activity detected
in somatic cells of testes in adult ARO-iCre males. After crossing the ARO-iCre mice with a ROSA26 Cre
reporter mouse, β-galactosidase activity was detected in both SC and LC. No activity was present in germ
cells. Right micrograph, low magnification; left micrographs, details in higher magnification. ST, seminiferous
tubules. In, interstitium. Arrow head points to SC. Bar represents 50 μm.
doi:10.1371/journal.pone.0119392.g001
Phenotype of TRαAMI-AROMice
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TRαAMI/WT;ARO-iCre+/0 mice, hereafter called TRαAMI-ARO. These double transgenic mice
efficiently express the targeted dominant-negative TRα1 isoform in SC and in LC. TRαAMI/WT
littermates that tested negative for ARO-iCre were used as control mice throughout this study.
Genotyping of the mice was performed using the primers for iCre and TRαAMI alleles listed in
Table 1.
Fertility, testis weight and sperm reserve
TRαAMI-ARO mice and their controls were sacrificed and one testis weighed and frozen for
sperm reserve determination as described for TRαAMI-SC [8]. Briefly, testes were disrupted in
3 ml of L15 medium (Gibco-Invitrogen) and sonicated for 30 s. Remaining sperm nuclei were
counted using a hemocytometer method. These nuclei contain spermatozoa and stage II-VII
elongating spermatid nuclei, and their number defines the testicular sperm reserve [3]. Each
male (n = 10 per genotype) was mated with two primiparous Swiss female mice. The birth
dates were noted to detect a putative delay in mating, and pups were counted at birth.
Histology
Testes were fixed in Bouin’s solution and embedded in paraffin. Sections 4 μm thick were
stained with hematoxylin for microscopic observation of seminiferous tubule organization.
Determination of SC proliferation index in vivo and in vitro
Procedures were previously described for TRαAMI-SC [8]. Briefly, TRαAMI-ARO mice at P3
were injected with 50 μg per gram of body weight of 5-bromo-2-deoxyuridine (BrdU, Sigma)
3 h before sacrifice. After fixation in Bouin’s solution and embedding in paraffin, BrdU immu-
nodetection was performed (monoclonal antibody from Roche; 1:200). A total of 1000 prolifer-
ating (BrdU-stained) and non-replicating (BrdU-negative) SC were counted per animal using
Histolab analysis software (GT Vision). For organotypic cultures, TRαAMI-ARO testes at P3
were cut into small pieces. Culture conditions were as described previously [26], except that T3
(0.2 μM) or a vehicle (1X PBS with 0.025 N NaOH) was added to the medium. Explants were
cultured for 72 h and BrdU was added at a final concentration of 0.01 mg/ml after 69 h (i.e. 3 h
prior to fixation, exactly as in vivo). The explants were then fixed in Bouin’s fixative and pro-
cessed for BrdU staining.
RNA extraction, reverse transcription and PCR for TRα1 detection
Total RNA was isolated from whole testes at post-natal day 0 (P0), 3 (P3), 10 (P10), 22 (P22)
or adulthood (pool of 3 animals per age) and from Sertoli and Leydig cell-enriched fractions
obtained at P10 and prepared as described previously [8]. RNA (1 μg) was reverse transcribed
using the RNeasy kit (with DNAse I) according to the manufacturer’s instructions (Qiagen). A
sample with RNA but without reverse transcriptase (RT-) served as a negative control. TRα1
Table 1. Primers for PCR genotyping of TRαAMI-ARO line and for RT-PCR of TRα1 [27] and actin genes.
Gene Forward PCR primer (5’-3’) Reverse PCR primer (5’-3’) Temp. Length
TRαAMI GGTTGGTCCAAGGAAAGACA GCTTCTTGCCGTTTGAAGAC 60°C 520 bp
iCre CCTGGAAGATGCTCCTGTCTG AGGGTGTTGTAGGCAATGCC 58°C 391 bp
Actin TACGACCAGAGGCATACAGG TGACCCAGATCATGTTTGAGA 55°C 411 bp
TRα1 TGCCTTTAACCTGGATGACAC TCGACTTTCATGTGGAGGAAG 60°C 720 bp
doi:10.1371/journal.pone.0119392.t001
Phenotype of TRαAMI-AROMice
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mRNA was detected as described [27] by classical PCR using primers and hybridization tem-
peratures as described in Table 1. The β-actin gene was used to control RNA quality.
Quantitative real-time PCR for analysis of testicular steroidogenesis
Three key steroidogenic genes were analyzed using the TaqMan assay, with primers and probes in-
ventoried by Applied Biosystems: StAR (Steroidogenic acute regulatory protein), Mm00441558_m1;
Cyp11a1/P450scc (cytochrome P450 side-chain cleavage enzyme), Mm00490735_m1; Cyp17a1/
P450c17 (steroid 17 α hydroxylase/17,20 lyase cytochrome P450c17), Mm00484040_m1. PCR re-
agents were purchased from Applied Biosystems and real-time PCR carried out in accordance with
the manufacturer’s instructions, in a final volume of 25 μl. Samples were analyzed in triplicate. Fluo-
rescence was detected on an iCycler BioRad apparatus. Negative controls (RT- and H20) were in-
cluded for every primer/probe combination. Normalization was performed using two internal
standards, β-actin (Mm00607939_s1) and Gapdh (m99999915_g1) from the same sample. The nor-
malized cDNAwas compared between the two genotypes.
Blood collection and hormone assays
Around 500 μl of blood were obtained by retro-orbital sampling in anesthetized mice (with keta-
mine 87 μg/g body weight and xylazine 13 μg/g body weight; intraperitoneal injection) and col-
lected in a tube containing EDTA (0.13 M). For plasma testosterone determinations, adult mice
were treated with an intraperitoneal injection of 15 IU of human chorionic gonadotropin (hCG)
(Chorulon). Blood was collected before (basal level) and 2 h after injection (stimulated level).
Plasma was stored at -20°C until tritium-based testosterone competitive radioimmunoassays.
RIA are carried out regularly in the lab and were performed as described [8]. The sensitivity of
the assay was 0.125 ng/ml. The intra-assay coefficient of variation was 7.5%. Briefly, samples
(two different dilutions per sample) or testosterone dilutions (to determine the range) were incu-
bated for 1 h at 40°C (0.1 M phosphate buffer, 0.1% gelatin) with tritiated testosterone plus the
anti-testosterone antibody. A secondary antibody was added and the mixtures incubated over-
night at 4°C. Subsequent immuno-precipitation was performed with PEG (polyethylene glycol)
4000 and the radioactivity was counted (Packard C2900 TriCarb). Plasma LH (luteinizing hor-
mone) levels were determined in a volume of 50 μl using the immuno-enzymatic LH-DETECT-
kit for rodents from ReprodPharm, according to manufacturer’s instructions, except that the
antibody was used at 4°C overnight, with tetramethylbenzidine as the substrate.
Statistical analysis
All data are presented as mean ± SEM. To compare means between two groups, Student’s t-test
or Mann-Whitney U test, in case of differences in variance (Fisher’s exact test), was used.
Other comparisons were performed using a two-way ANOVA followed by the Bonferroni
post-hoc test. P< 0.05 was considered significant.
Results
Generation of an ARO-iCre transgenic strain
ARO-iCre transgenic mice were generated as indicated in materials and methods (Fig. 1A). We
characterized the ARO-iCre line first by crossing iCre positive animals with mice carrying a floxed
conditional gene. Monitoring Cre excision with the TRαAMI allele is technically challenging be-
cause it only diverges from the wild-type TRα1 by a single amino acid mutation [25]. Therefore,
we used the floxed allele of the insulin-like growth factor-1 receptor (IGF1R) gene [28–30] for
characterization. IGF1R excision was analyzed in various organs of iCre+/0;IGF1Rflox/WT pups
Phenotype of TRαAMI-AROMice
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using triplex PCR on genomic DNA [24]. We found the excised allele exclusively in samples from
male and female gonads (Fig. 1B), confirming the promoter characterization of Hinshelwood
et al. [23] and demonstrating the usefulness of the transgenic line for functional gonad investiga-
tion. In particular, we did not observe any excision in the brain (Fig. 1B), nor in the pituitary (not
shown). To characterize the ARO-iCre transgenic line at cellular level, we crossed it to mice con-
taining the ROSA26 Cre reporter (R26R) allele [31]. β-galactosidase (β-gal) activity resulting from
loxP recombination at the R26R locus by ARO-iCre recombinase was observed at the periphery of
the seminiferous tubules in SC and in the interstitium containing LC (Fig. 1C). In contrast, no ac-
tivity was present in germ cells. β-galactosidase (β-gal) activity was also observed in most intersti-
tial cells and seminiferous tubules at P3 (S1 Fig.), in accordance with Cyp19/aromatase expression
in testes.
Next we demonstrated that the TRα1 gene was expressed in mice by LC and SC during
post-natal development (Fig. 2).
We then aimed to produce transgenic mice with impaired function of this receptor in both
cell types to compare these mice with the previously established TRαAMI-SC [8]. After having
checked that ARO-iCre was useful for Cre-loxP excision in both SC and LC cells (Fig. 1C), we
produced TRαAMI-ARO double transgenic mice as described in materials and methods. Litter-
mates with the unrecombined TRαAMI allele and negative for ARO-iCre served as control
mice. Testicular function was then studied at physiological, cellular and hormonal levels. A
summary of the results is presented in Table 2.
Fig 2. RT-PCR detection of TRα1 mRNA in testes during post-natal development in wild-typemice.
TRα1 mRNA (720 pb) was present in whole testes from birth (P0) to P22, and in SC- and LC-enriched
fractions prepared from testes of wild-type mice at P10. TRα1-specific primers were described previously [27]
(Table 1). Actin mRNA (411 pb) was detected to check RNA quality. RT-, control without RT.
doi:10.1371/journal.pone.0119392.g002
Table 2. Physiological, endocrine and cellular characteristics in TRαAMI-ARO (present study), TRαAMI-SC and TRαNull/Null transgenic lines.
Mutant strain TRαNull/Null TRαAMI-SC TRαAMI-ARO
Mutation Gene knockout [27] Dominant negative knock-in [25] Dominant negative knock-in [25]
References (phenotype) [7, 8] [8] Present study
Target cells ubiquitous Sertoli Sertoli & Leydig
Adult testis weight (% change) +26.7% *** +14.2% *** +16.5% ***
Testicular sperm reserve increased *** increased ** increased ***
SC proliferation index (P3) increased *** increased *** increased ***
Histology of seminiferous tubules unchanged [7] unchanged unchanged
Blood testosterone level (basal and stimulated) normal normal normal
Blood LH level ND ND normal
**P < 0.01;
***P < 0.001;
ND, not determined.
doi:10.1371/journal.pone.0119392.t002
Phenotype of TRαAMI-AROMice
PLOS ONE | DOI:10.1371/journal.pone.0119392 March 20, 2015 7 / 15
TRαAMI-AROmales present increased sperm reserve and normal fertility
We were particularly interested to find out whether the presence of the TRαAMI allele in both
SC and LC has the same consequences in adults as in TRαAMI-SC males, in which testis weight
was high due to an increase in sperm reserve. Adult TRαAMI-ARO males were normally fertile
(TRαAMI-ARO, 12.6 ± 1.2 pups per male; control, 12.0 ± 1.6 pups per male; n = 10 males per
genotype). Histological analyses revealed no visible alteration of the seminiferous tubule epi-
thelium (Fig. 3). In TRαAMI-ARO males we observed a significant increase (P< 0.001) in the
total testicular sperm reserve (Fig. 4A) and in testis weight (Fig. 4B) in comparison with
the control.
SC proliferation index increased in TRαAMI-ARO just as TRαAMI-SC mice
In TRαAMI-SC males, we previously observed that the increase in sperm reserve resulted from
an augmentation in the SC proliferation rate during post-natal development. The next step was
to ask if the TRαAMI allele in both SC and LC accentuate these cellular changes. To reach this
aim, we investigated the percentage of SC incorporating BrdU within 3 hours at P3, in vivo and
in vitro. In vivo, we found the SC proliferation index was significantly higher (P< 0.001) in
TRαAMI-ARO testes than in control testes at P3 (Fig. 4C). We then wanted to know if the regu-
lation exerted by TRα1 on the SC proliferation index described above was modulated in the
presence of T3. To do so, we used organotypic cultures in which SC proliferation was measured
in testes explanted at P3, in the presence or absence of exogenous T3. In organotypic cultures,
SC proliferation without T3 (vehicle) was similar for TRαAMI-ARO and control testes, indicat-
ing that the TRα1 dominant-negative did not alter SC proliferation in the absence of T3 in
vitro (Fig. 4D). As expected, addition of T3 significantly (P< 0.001) decreased (approximately
two-fold) SC proliferation in the controls, whereas this response was fully abolished in
TRαAMI-ARO.
Testosterone and LH levels are unchanged in adult TRαAMI-AROmice
We then tried to find out whether the TRαAMI allele present in LC affects their steroidogenic
activity, compared with the TRαAMI-SC phenotype, where plasma testosterone levels were un-
changed. For this, we measured basal and hCG-stimulated testosterone levels. Both basal and
hCG-stimulated testosterone levels were similar in adult TRαAMI-ARO and the controls, with
significant effects of hCG stimulation in both lines, as could be expected (Fig. 5A).
To consolidate the androgenic status of TRαAMI-ARO, we investigated mRNA levels of ste-
roidogenesis enzymes P450c17 (Cyp17a1), P450scc (Cyp11a1) and StAR per testis, which were
Fig 3. Histological sections of adult TRαAMI-ARO testes at low (a) and high (b) magnification.
Seminiferous tubules were fully developed in TRαAMI-ARO. Their epithelium exhibited normal structure and
organization. Hematoxylin staining. Bar represents 100 μm.
doi:10.1371/journal.pone.0119392.g003
Phenotype of TRαAMI-AROMice
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all unaffected (Fig. 5B). Moreover, as expected, LH levels were similar in TRαAMI-ARO males
and control males (0.85 ng/ml ± 0.4 in TRαAMI-ARO versus 0.63 ng/ml ± 0.2 in control, n = 6
for each genotype).
Discussion
A new genetic mouse model to study testicular somatic cells
We previously used the TRαAMI allele that induces constitutive T3-regulated gene repression
by preventing interaction with coactivators [25,32]. We used the TRαAMI allele to demonstrate
that T3 controls post-natal SC proliferation through TRα1 in a direct and cell-autonomous
manner during early post-natal development [8]. Here, we present the introduction of this con-
ditional dominant-negative allele in post-natal testes in both LC and SC compartments using
the novel ARO-iCre transgenic mouse strain generated in our lab.
We showed that Cre activity of the ARO-iCre line was restricted to male and female gonads,
confirming the highly specific Cyp19/aromatase(IIa)-278 promoter expression profile [23]. In
contrast, other available gonad-specific Cre transgenic lines driving recombinase expression in
steroidogeneic cells, are also active in cells from others tissues, namely adrenal tissue and
Fig 4. Whole testicular sperm reserve and testis weight in adult TRαAMI-ARO, and percentage of
proliferating SC in TRαAMI-ARO at P3 in vivo and in testicular explants using organotypic in vitro
cultures with or without exogenous T3.We observed a significant increase in whole testicular sperm
reserve (a) and in testis weight (b) (***P< 0.001; n = 15 for controls and n = 16 for TRαAMI-ARO group).
Data are shown as mean ± SEM. Statistical analyses were performed using Student’s t-test. White bars,
control; black bars, TRαAMI-ARO (a, b). After BrdU immunohistochemical labeling, BrdU negative and BrdU
positive SC were counted and the SC proliferation index was calculated. (c)When BrdU was injected in vivo
3 h before sacrifice, proliferation of Sertoli cells increased in P3 testes of TRαAMI-AROmice in comparison
with the control (***P< 0.001; n = 5 animals for each genotype). (d)When BrdU was added in vitro 3 h
before the end of the organotypic cultures of P3 testicular explants, the SC proliferation index significantly
decreased in the control in presence of T3 compared with vehicle (***P< 0.001, n = 6). In contrast, T3 had
no effect on SC proliferative index in TRαAMI-AROmice (P> 0.05, n = 5). Data are shown as mean ± SEM.
Statistical analyses: two-way ANOVA followed by Bonferroni’s post-hoc test. White bars, control; black bars,
TRαAMI-ARO.
doi:10.1371/journal.pone.0119392.g004
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hindbrain for the Cyp11a-GC (GFP-Cre) line [33], and male adrenal tissue for the Cyp17-iCre
line [34]. In the literature, the anti-Müllerian hormone type 2 receptor (AMHR2)-Cre line [35]
was mostly used to target conditional gene mutation in LC, for instance for the genes coding
for SF1 [36], androgen receptors [37] or ALK3 [38], but also in SC, for example to impact
WNT/beta-catenin signaling [39].
We characterized testicular iCre activity using a ROSA26 Cre reporter mouse. We detected
loxP recombination in both SC and LC at P3, an age when SC are highly proliferative. This re-
sult is fully coherent with the aromatase expression profile observed in post-natal testes. Aro-
matase activity corresponds to the irreversible conversion of androgens into estrogens [40]. In
LC, this activity increases progressively from birth to puberty as the testis matures [41,42]. In
SC, which only express aromatase during post-natal development, activity decreased 2-fold
from birth to 2 weeks of age. Consequently, estrogens are almost exclusively produced by LC
during adulthood [43].
In our model, we observed a phenotype similar to TRαAMI-SC obtained with AMH-Cre
which is known to target all SC, suggesting that the ARO-iCre is rapidly active in the majority
of post-natal SC. The absence of ARO-iCre activity in male germ cells, evidenced by a lack of
Fig 5. Plasma testosterone levels in adult TRαAMI-AROmales, in basal conditions and after hCG
stimulation, compared with control mice andmRNA levels of Cyp11a1/P450ssc, Cyp17a1/P450c17
and StAR in TRαAMI-ARO testes. (a) In both TRαAMI-ARO (11 males) and controls (9 males), hCG induced a
significant increase (***P< 0.001) in testosterone secretion, as expected. Plasma testosterone levels were
unchanged in TRαAMI-ARO compared with the control. Data are shown as mean ± SEM. Two-way ANOVA
followed by Bonferroni’s post-hoc test. Black bars, basal levels; white bars, hCG stimulated. (b) The amount
of cDNA of 3 steroidogenic genes (Cyp11a1/P450ssc, Cyp17a1/P450c17 and StAR) was compared in
TRαAMI-ARO (black bars) and control males (white bars). For each genotype, 6 mice were tested in triplicate
using TaqMan quantitative real-time PCR, as described in materials and methods. Normalization was
performed with two housekeeping genes, β-actin and GAPDH, that both exhibited similar expression among
samples. mRNA expression is presented as percent of mean control level. A non-parametric test (Mann-
Whitney) was used for statistical analysis. NS: not significant.
doi:10.1371/journal.pone.0119392.g005
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β-galactosidase staining and no transmission of the deleted allele to offspring (data not shown),
is in full agreement with Hinshelwood et al. [23], who showed that the Cyp19/aromatase(IIa)-278
promoter did not target Cre in oocytes.
Phenotype of TRαAMI-AROmales and parallel with TRαAMI-SC
We compared the TRαAMI-ARO line, which presents a constitutive repression of the T3/TRα1
pathway in LC and SC—a kind of local hypothyroidism—with the TRαAMI-SC and TRαNull/Null
lines (summarized in Table 2). In early post-natal TRαAMI-ARO testes, the SC proliferation
rate was similar to the rate observed in TRαAMI-SC of the same age, which explains why the in-
crease in sperm reserve and in testis weight are of similar magnitude in adulthood in both
lines. These results are not surprising since the KO of THRA (TRαNull/Null line) led to similar
effects.
In adult TRαAMI-ARO males compared with their controls, we did not observe any change
in plasma testosterone and LH levels, nor in steroidogenesis enzyme expression in testes. These
converging observations support that local hypothyroidism induced before puberty by a domi-
nant-negative TRα1 receptor does not influence LC steroidogenic activity, directly or indirect-
ly, through putative SC-pathways. In the literature, on experiments in rats and humans, and
despite abundant documentation of T3-dependent regulation of LC precursor cell differentia-
tion [44,45], this point was controversial, depending on the model and the experimental ap-
proach used. In rats made hypothyroid with propil-thiouracil treatment during post-natal
development or adulthood, it was observed that peripheral testosterone concentrations were
unchanged [4,16,17,46,47]. In contrast, more recent studies on neonatal rats made hypothyroid
using methimazole showed a different result, concluding that T3 increases testosterone pro-
duction [18,19]. Yet another study, using thyroidectomy and thyroid hormone supplementa-
tion, showed a negative influence of T3 on testosterone production, along with decreased LH
and FSH levels [48]. The degree of hypothyroidism could influence the impact on steroidogen-
esis and discrepancies may be due to the various molecules used to develop hypothyroidism,
and/or by the timing of the pharmacological treatment. In humans as well, the impact of T3 de-
regulation varies from case to case (for review [49]), with decreased [50,51] or unchanged [52]
blood testosterone levels in hypothyroid men. Our results suggest that the testosterone and LH
endocrine disturbances observed in various hypothyroid animals (including humans) are prob-
ably more related to a disturbance at central level of the hypothalamo-pituitary axis than at go-
nadal level. Moreover, the discrepancies between pharmacological and functional models
suggest that such perturbations may be the result of cumulative effects of T3 via TRα1 and pos-
sibly TRβ1, as we discussed in our previous work [8]. Indeed, whereas TRβ2 appears to be re-
stricted to the nervous system, TRβ1 is expressed in various testis cells. Therefore, this receptor
may directly transduce certain T3 functions in LC and/or SC, in addition to TRα1 (for review
see [53,54]). It is possible that TRβ1 may palliate TRα1 in case of loss of receptor function. As
discussed in our previous work, the systematic analysis of mice expressing the TRαAMI allele in
various tissues suggests that most TRβ functions are preserved in this model [25,55], explaining
the fact that the TRαNull/Null testis phenotype does not fully recapitulate post-natal hypothy-
roidism. In particular, in the present TRαAMI-ARO, TRβ1 could have significant function in
Leydig cells, equilibrating testosterone levels.
A final point is the role of SC paracrine factors in the regulation of LC, with some of them
putatively regulated by T3 during post-natal development, such as insulin-like growth factor-1
[54,56]. However, the TRαAMI-ARO phenotype suggests that such regulation through TRα1 is
negligible, and this result is concordant with our previous study in which TRαAMI in SC alone
did not affect testosterone levels.
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Conclusion
Our work has confirmed the role of TRα1 in SC during post-natal life and pointed out that T3
does not, or only moderately, regulate steroidogenic activity through this receptor, whether in
a direct LC-autonomous manner, or indirectly through SC paracrine regulation. This study
also brings forward an additional genetic tool (i.e. the ARO-iCre line) to investigate LC func-
tion. Further characterizations of this model should define precisely the timing of Cre activity
and its localization in the ovary.
Supporting Information
S1 Fig. characterization of ARO-iCre transgenic mouse line at P3. Cre recombinase activity
detected in somatic cells of testes in ARO-iCre males at P3. After crossing with a ROSA26 Cre
reporter mouse, β-galactosidase activity was detected in both ST (seminiferous tubules) and In
(interstitium). Bar represents 50 μm.
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